The RCVS has launched an online petition calling on Parliament to protect the title ‘veterinary nurse’ in law.
The petition follows on from the work done by the College earlier in the year, drawing up the ‘Veterinary Nurse (Protection of Title) Bill’ which was submitted to a ballot of the House of Lords in May by former RCVS President and Council member Professor the Lord Trees and received its first reading on 10 June.
Unfortunately, Lord Trees' Bill was drawn low in the ballot, so it is now thought unlikely - though not impossible - that it will be given time for a second reading in this parliament.
Nevertheless, the College is continuing to try and raise awareness of the issue, both amongst the public and parliamentarians. If the petition gains enough signatures, it should maximise the chances of the Bill being given a proper airing in parliament, this year or in the future.
Liz Cox, the Chair of VN Council, said: “We believe that the fact that anybody can call themselves a veterinary nurse is unacceptable. It means that there is potential for the public to be misled and for animal health and welfare to be compromised. Therefore we would urge veterinary nurses, veterinary surgeons and animal owners to sign this petition. With 10,000 signatures the Government is obliged to respond formally and take a stance on the issue; with 100,000 signatures the issue would be considered for a formal parliamentary debate.
“If we are successful with this campaign, the public will be assured that they are receiving the highest standard of nursing care for their animals from a genuine professional and by protecting the title we can remove any doubt about who is a veterinary nurse.”
In conjunction with the petition, the RCVS has also produced a template letter which the profession and public can use to write to their local Member of Parliament asking them to support the campaign. For example, the letter asks the MP to adopt the Veterinary Nurse (Protection of Title) Bill and enter it into a Private Members’ Bill ballot or introduce it as a 10-Minute Rule Bill.
The petition, and the campaign in general, has received support from the BVNA and the British Veterinary Association BVA.
Fiona Andrew, President of the BVNA, said: “BVNA has campaigned for the protection of the title of 'Veterinary Nurse' for many years. We are delighted that the RCVS is continuing the campaign with the addition of the online petition and letter template.
“We would ask all out members to sign the petition and write to their MP. We believe that this is an important step towards giving clarity and reassurance to the public, strengthening the profession and raising awareness of what veterinary nurses can do and enhancing animal welfare.”
John Blackwell, President of the BVA, added: “BVA is delighted to support the campaign to protect the title, as veterinary nurses are an essential part of the veterinary team and deserve full recognition for their roles. By protecting the title it not only recognises the skills of qualified veterinary nurses, but also gives clients confidence that their animals are receiving the highest standard of care possible.” Those who wish to sign the petition can do so on the UK Government and Parliament petition website https://petition.parliament.uk/petitions/106153 To find out more about the campaign, download a template letter to an MP and view the College's animated video about protecting the title, visit www.rcvs.org.uk/vntitle
Zoetis has announced the launch of Zulvac SBV, a new Schmallenberg vaccine licensed for use in cattle and sheep in two doses at a three week interval, the second at least two weeks before mating.
Zulvac SBV is licensed for use in cattle and sheep in two doses at a three week interval, the second at least two weeks before mating.
Duration of immunity is six months in cattle and seven in sheep. At the recommended vaccination timing, this covers the window of susceptibility during pregnancy; in sheep from day 28 to 56, and days 70 to 150 in cattle. Animals infected during these periods are at risk of malformed offspring and subsequent stillbirth.
The company says vaccination combined with insecticidal measures to control the midge vector remains the most effective way of protecting the population1 and ensuring a more unified level of immunity.
Zoetis vet Carolyn Hogan said: "Although SBV is now considered to be an enzootic pathogen in England and Wales, there is plenty of evidence that seroprevalence at farm level – particularly on sheep farms - varies. As immunity wanes, the proportion of herds and flocks naïve to SBV and at risk via introduction of naïve replacements increases. So the risk of reinfection in assumed enzootic areas is potentially underestimated2.
"Culicoides midges, the SBV vector, are widespread in Europe and move easily between farms and regions, allowing rapid spread of infection."
Carolyn says that whilst there have been no confirmed diagnoses of congenital abnormalities in calves or lambs from APHA in 2014 or 2015, unconfirmed anecdotal cases have been reported.
"We do not know whether our ruminant population is immune or susceptible and neither do we know if another SBV challenge will appear. Vaccination remains the most effective way of ensuring valuable livestock are protected."
Supplies are available immediately.
References
The RCVS Disciplinary Committee has agreed to accept undertakings from a Dorset veterinary surgeon, Philippa Ann Rodale MBE, in which she requests that her name is removed from the RCVS Register of Veterinary Surgeons with effect from 31 July 2015, and undertakes never to apply to be restored to it.
The Committee met on Monday 17 August, resuming a hearing which had been adjourned on 20 July. The adjournment had been made to allow Ms Rodale time to submit formal responses to the charges against her and indicate whether she agreed with them. In the event, as outlined by a letter from her solicitors received by the College on 14 August, Ms Rodale declined to comment on the charges and did not admit to any of them.
Ms Rodale did not attend the hearing on 17 August, however, the Committee decided to continue in her absence, on the understanding that, as evidenced by her solicitors’ letter, she was fully aware of the hearing and had voluntarily waived her right to be presented and represented.
The original charges related to Ms Rodale’s standards of practice (in relation to issues such as biosecurity, hygiene, in-patient facilities, drug storage and the disposal of hazardous waste, among other things) and also to a test for Intradermal Comparative Tuberculin. The charges relating to her standards of practice did not have complainants, as the College raised the matters itself; with respect to the Tuberculin test charge, the Animal and Plant Health Agency, as the relevant body, raised no objection to the proposed course of accepting undertakings.
In accepting the undertakings, the Committee felt that a contested hearing that could take up to seven days and involve up to eight witnesses for the College and up to three for the Respondent would not be in the public interest. Furthermore, since the 20 July hearing, Ms Rodale had retired and closed her practice. The Committee also noted that there had been no previous disciplinary findings against her, in what was otherwise a long and unblemished career.
Ian Green, chairing the Committee and speaking on its behalf, said: “The Committee is satisfied that the undertakings offered by the Respondent protect the welfare of animals since the Respondent has now retired and is no longer in practice. It is also satisfied that the reputation of the profession is upheld since the undertakings offered go beyond any sanction which the Committee could impose at the conclusion of a contested hearing, were any of the Heads of Charge to be found proved. It considers that it would not be proportionate or in the public interest for there to be a lengthy contested hearing.”
Vet Futures has published the results of a survey of the profession in which only half of veterinary surgeons who graduated within the last eight years say their career has matched their expectations.
The online survey gathered views from 892 veterinary students (via the Association of Veterinary Students) and 1,973 veterinary surgeons who had graduated within the last eight years, during May and June this year.
Although 37% of graduates reported that their working lives had met their expectations, and a further 13% said it had exceeded them, this left 50% partly or wholly unsatisfied. Furthermore, 10% said they were considering leaving the profession entirely.
The RCVS and the BVA say the results should be a “wakeup call” to the profession.
Vets who have been qualified for five years or more were least optimistic about the future, rating their opportunities for career progression less positively than more recent graduates. They were also least likely to feel that their degree had prepared them for their current work. Meanwhile, only 34% of students felt that their degree was preparing them ‘very well’ for the work they wanted to do.
73% of students intended to work in the UK, with most aspiring to work in small animal/exotic or mixed practice, although one in 10 was as yet undecided. Of the students, 45% said they wanted to become practice owners or partners. Clearly the reality is proving less enticing, because only 25% graduates shared the same aspiration. In addition, nearly double the number of graduates said they wanted to work outside clinical practice (18%), compared to students.
When looking for a job, the three factors that both graduates and students agreed would have the greatest influence on their choice of career were intellectual satisfaction, location and a supportive environment.
This last requirement chimes with the fact that among the most popular suggestions for improvement to the veterinary degree were compulsory modules on managing stress, personal development and work-life balance, alongside more teaching of business and finance skills, and extra-mural studies (EMS) placements in a wider range of settings, such as industry.
BVA President, John Blackwell, said: “The drop off in career satisfaction for vets during this crucial first eight years in practice is something we can’t afford to ignore. It points to frustration over career development opportunities and dissatisfaction with support available in practice. For the veterinary profession to remain sustainable, and an attractive career choice for the best and brightest, we need to address these issues with some urgency.”
RCVS President, Dr Bradley Viner, said: “We clearly need to address the disconnect between expectation and reality for many recent graduates. Reviewing the educational foundation of the profession is a thread that runs through many of the proposed actions that will be outlined in the Vet Futures report due this autumn. The teaching and assessment of non-clinical skills – both as part of the undergraduate curriculum and within postgraduate education – will be important, as will be the promotion of non-clinical career pathways.”
The survey also covered issues such as students’ aspirations in terms of the type (size, ownership, sector) of practice in which they would like to work, and graduates’ future career plans. It also considers attitudes from both groups with respect to new technology.
The full research report “Voices from the future of the profession,” can be read at www.vetfutures.org.uk/resources.
Animalcare has announced the launch of Clavubactin (amoxicillin/clavulanate) for dogs and cats, presented as 4-way split tablets in three strengths to ensure optimum dosing. The three strengths (Clavubactin 50, 250 and 500) contain 50/12.5, 250/62.5 and 500/125mg of amoxicillin and clavulanic acid respectively. Clavubactin 50mg is licensed for cats and dogs. The 250 and 500mg formulation is licensed for dogs only.
According to the company, the increased combined level of active ingredients, compared to some other clavulanate-amoxicillin products on the market, achieves recommended target weight dosing (doses always kept at 12.5mg/kg), even with animals of greater weight, minimising the risk of underdosing.
The 4-way split tablets are designed to facilitate easy and accurate dosing of all sizes of dogs and cats, from 1kg bodyweight (¼ tablet Clavubactin 50) to 50kg (1 tablet Clavubactin 500) and above.
The tablets come in aluminium blister strips of ten tablets in five packaging presentations (Clavubactin 50 and 250 are available in 100 and 250 tablet packs and Clavubactin 500 in 100 tablets).
Animalcare Product Manager Tony Liepman said "Clavubactin allows for optimum target weight dosing and together with the accuracy enabled by SmartTabs easy 4-way split, this gives peace of mind to both vet and client."
The product is supported by dosage charts and dispensing envelopes (the latter is available on request).
For further information contact Animalcare on 01904 487687, speak to your regional Animalcare representative or visit www.animalcare.co.uk/contact-us.
The organisers say that the presentations have been designed to be practical in nature and to provide delegates with useful, take-away information they can apply immediately in practice and that isn’t readily available in textbooks.
Forty-eight presentations will be staged over the two-days across four themed lecture strands: three for vets and a dedicated strand for Veterinary Nurses, although delegates are free to attend any lecture they choose.
The core themes for vets include Orthopaedics, Neurology and Oncology and Soft Tissue Surgery. The Veterinary Nursing strand will cover topics such as Anaesthesia, Arthritis, Cancer, Trauma, Spinal Nursing, Pain Management, Rehabilitation and Nutritional Advice.
Presentations include:
An overarching theme for the festival is ‘One Medicine’, the emerging global concept of combined human and animal medical advancement for the good of all species; Noel Fitzpatrick will give a keynote speech on Saturday 5th September on this subject.
On Sunday 6th September, the closing keynote speech will be delivered by Dr Jane Goodall DBE who will talk about her work as a British Ethologist, conservationist and UN Messenger of Peace and the importance of preserving habitats, species and biodiversity to the continuance of mankind.
A full speaker agenda is available at www.vetfestival.co.uk and attendance at the Festival can be added to delegates’ CPD records.
On Saturday evening, the Festival will host ONE LIVE, a music festival open to delegates, their families and the general public in aid of The Humanimal Trust, a charity inspiring advancement of healthcare initiatives in animals at the same time as humans. Headlining the concert will be Mike and The Mechanics with support from The Hoosiers and Hunter and The Bear.
Tickets for VET Festival cost from £99. There are discounted rates available for Veterinary Nurses and Students and groups of five or more vets or vet nurses can receive a group discount. For more information and to book tickets visit www.vetfestival.co.uk
VetSurgeon.org has 4 free tickets for the full 2 day festival to give away, and a further 12 tickets to the evening concert. We'll be dishing them out randomly amongst those VetSurgeon members who indicate their interest in attending the event by clicking the RSVP button on the entry in the VetSurgeon CPD & Events Diary, here: http://www.vetsurgeon.org/c/veterinary-cpd/events/5.aspx
The RCVS has launched a new animated video to help promote Practice Standards Scheme (PSS) accredited practices to the public, and explain the benefits of the scheme.
Launched in 2005, almost 60% of practices are now part of the PSS, which requires them to submit to a rigorous inspection every four years and meet a stringent standards across a wide range of areas including cleanliness and hygiene, facilities and equipment, staff training and development and customer service. Practices may also be subject to spot-checks between inspections.
Jacqui Molyneux, who heads up the RCVS Practice Standards Group said: “Our new video is a light-hearted explanation of the Practice Standards Scheme, how it can help animal owners decide which practice to go to and reassure them about the standards they can expect to find at an RCVS-accredited practice.”
The College says a similar version of the video will soon be available for RCVS-accredited practices to show to their clients, either on their own websites and social media channels, or in the waiting room.
Jacqui said: “Not only do we want to spread the word about the benefits of the Practice Standards Scheme and suggest animal owners look for the RCVS-accredited practice logo, but we also want to give accredited practices an engaging way of telling their clients about their achievement.
“Gaining RCVS accreditation is not easy, so accredited practices deserve every opportunity to demonstrate to their clients their commitment to supporting high standards of veterinary care. This fun two-minute video should help them do just that.”
Animal owners can search for an RCVS-accredited practice in their area, or elsewhere in the UK, using Find A Vet – the College’s online search tool – at www.findavet.org.uk.
Zoetis has announced the launch of Versican Plus, a vaccine range for dogs in the UK and throughout Europe.
Versican Plus is the only vaccine to combine DHPPi + L4 in a single injection1, something which Zoetis says is the fruit of several years research and development.
The leptospirosis components of the vaccine have been designed to meet the challenges of both existing and emerging types.
According to the company, Versican Plus is the only tetravalent leptospirosis vaccine to deliver prevention against clinical signs and urinary excretion of established (Icterohaemorragiae and Canicola) and emerging (Bratislava and Grippotyphosa) canine leptospirosis (except Grippotyphosa where prevention of clinical signs occurs but with a reduction in urinary excretion).
Zoetis also highlights the advantage this vaccine brings is in its viral components. Versican Plus utilises a new CPV-2b strain, the most prevalent strain in the UK2, to prevent clinical signs, leucopoenia and viral excretion caused by Parvovirus.
Practices using Versican Plus will have the ability to provide protection at the earliest opportunity, as it has been proven to be protective against virulent challenge in the presence of maternally derived antibodies to Parvovirus, Distemper and Adenovirus at levels equal or higher to those likely to be encountered under field conditions.
As a result Versican Plus can be used from 6 weeks of age with an early onset of immunity being achieved for Parvovirus, Distemper and Adenovirus at 9 weeks. Parainfluenza and Leptospirosis immunity follow shortly thereafter at 12 and 13 weeks respectively.
Following primary vaccinations three to four weeks apart Versican Plus provides 3 years duration of immunity for Parvovirus, Distemper and Adenovirus.
Ned Flaxman, Zoetis UK Companion Animal director said: “Our research and development team has taken many different aspects of vaccination into account to create Versican Plus. As well as offering comprehensive protection in accordance with the current epidemiological situation, the vaccine is also convenient to use. It offers a flexible primary vaccination course with an early finish option from 9 weeks, important for early socialisation reasons.”
For further information, visit www.zoetis.co.uk/versicanplus, contact your Zoetis Account Manager or telephone 0845 300 8034.
Animalcare has announced the launch of Fungiconazol (ketoconazole), the UK's only veterinary licenced antifungal tablet for dogs, indicated for the treatment of ringworm.
Each Fungiconazol tablet contains 200 or 400mg of ketoconazole, to be administered at a dosage of 10mg per kg bodyweight once daily. Each tablet can be split into quarters or halves, allowing accurate treatment for dogs from 5kg (¼ x 200mg tablet daily) to 60kg (1½ x 400mg tablet daily) and beyond. The hypoallergenic chicken flavoured tablets mean that Fungiconazol is also suitable for dogs with food allergies or atopic dermatitis.
Animalcare Product Manager Tony Liepman said "This is a great addition to our antimicrobial range, and shows once again that it’s possible for us to be innovative without breaking anyone's budget. With the supply of the first and only licensed canine antifungal tablet on the market, we have ensured that all veterinary practices have access to Animalcare’s Technical Support department for further advice on treatment or its use in their patients."
Both 200mg and 400mg presentations of Fungiconazol, in 100 tablet blister packs, are now available from wholesalers.
For further information contact Animalcare on 01904 487687, or speak to your regional Animalcare representative (found at www.animalcare.co.uk/contact-us).
Pawz Ltd, a UK company founded by Diwaker Singh, Radu Georgescu and Francesco Cardoletti has launched PawSquad, a new on-demand veterinary video consultation service for pet owners.
The service offers pet owners a 15 minute online consultation with a veterinary surgeon for £15, any time from 6:00am to midnight, seven days a week.
PawSquad points out that the service cannot offer a diagnosis - apart from the fact that it would be contrary to the CoPC, it's obviously not possible without a physical exam - so the service is designed to offer more general health advice concerning such things as behaviour, nutrition and the management of long-term, non-emergency conditions.
Andrew Francis BVSc CertVC, DipECVIM-CA MRCVS ex-Head of Cardiology at Anderson Moores Veterinary Referrals is the company's Chief Veterinary Officer, sitting alongside Andrew Ash MRCVS (the BSAVA Past Pres). Andrew #1 said: "Currently, pet owners have only two options when they need advice about their pets' health and welfare. They either take time out of busy schedules to visit the vet or, when a visit to the vet is not possible they search the Internet for non professional and frequently unreliable information."
Francesco Cardoletti said: "It’s important to understand that PawSquad is a supplementary service – it’s not replacing traditional veterinary services.There are limits to the services you can digitally provide. If an animal is seriously ill, it needs to get to a bricks and mortar veterinary clinic and be examined by a vet."
Eleanor Ferguson, Head of Professional Conduct at the RCVS said: "We have had a discussion with Pawsquad and understand that the aim of its service is to increase accessibility to veterinary advice, which can only be a good thing as a large percentage of animal owners are not registered with a veterinary surgeon.
“We understand that the veterinary surgeons involved will not be giving detailed clinical advice but will be limited to offering general advice on areas such as puppy care, nutrition, allergies and pet passports.
“We also recommended to Pawsquad that their veterinary surgeons should take care to point out the limitations of their advice, given no physical examination has taken place, and suggest that owners takes their pets to a veterinary practice where that is appropriate.
“The issue of telemedicine has come up often during the joint RCVS/BVA Vet Futures project and is a topic that the Standards Committee, which looks after the Code of Professional Conduct and its supporting guidance, is currently considering in more depth, with an evidence-gathering process due next year.”
I tried out the new service with a question about my dog's slightly worrying habit of growling at one of my children. It was a question which we had not thus far raised with our normal vet because it hadn't been enough of a concern at the last consultation. But it seems to be getting slightly worse, and my wife and I had recently talked about getting advice. It seemed like just the sort of situation where an informal chat with a vet could be helpful.
Completing the preconsultation details was a breeze, slowed only by the need to shove the dog on a set of scales (I didn't know what she weighs, and it's needed for the consultation). Thereafter, only one hiccup when it transpired that Safari, the browser I was using, is incompatible. I switched to Chrome, which is.
The consultation itself was excellent. Within a few seconds, the very charming Angie Henderson MRCVS appeared on my screen. It transpired I was her very first consultation since the service was launched yesterday! We discussed the problem. She reassured me that one of the things I was doing (getting the child to feed the dog under supervision) was a good idea, and we discussed a number of other positive reinforcement strategies to try and improve our dog's behaviour. She explained that she wasn't one for certain types of negative reinforcement, but that using a spray bottle of water when the dog behaved inappropriately could help. She explained that we would need to do these things several times a day for them to have an effect, and even then it may take some considerable time, and may need the services of a behaviourist. She also reassured me that the dog would be unlikely to do anything worse than nip, whilst stressing that even a nip is very upsetting for a child, so it does need to be dealt with.
All in all, I came away reassured, with some very useful suggestions and a clear idea of what we need to do. £15 very well spent. I gather that I should also have received a written post-consultation report by email, which didn't arrive because of some technical glitch. But that's slightly by-the-by; the icing on the cake.
I can also see the service would be very useful as a sort of out-of-hours triage, in other words offering me the ability to have a "my-dog-has-just-eaten-three-kilos-of-Green-and-Blacks-what-next-consultation?" at 11:00pm at night.
If the service proves popular amongst pet owners, the question remains whether it will reduce the number of people seeking and paying for traditional consultations. I suspect not. Perhaps the reverse will happen as pet owners use the system to corroborate their feeling that the dog might need a physical exam. As part of the service and with your permission, PawSquad forwards a copy of the consultation report to your normal vet.
Again if the service proves popular, it seems to offer the potential for a nice additional income stream for veterinary surgeons, especially locums, which can be earned in the hours you specify, from the comfort of your home. PawSquad says it pays vets between £12-£32 per hour; equivalent to £60K per annum. Whilst the company doesn't directly employ vets, it will provide liability insurance provided by the VDS.
PawSquad says it also plans to recruit veterinary nurses later in the year, to offer advice to new pet owners on nutrition, behaviour and the environment.
European Specialist in Veterinary Dentistry Lisa Milella, who revealed last year that she has been diagnosed with motor neurone disease, has now announced that she plans to end her life at the Swiss-based organisation, Dignitas, and is calling on MPs to support a Private Members Bill on assisted dying, due for a second reading next month.
Speaking to the Daily Mail, Lisa said: "In Britain, we give more dignity in death to our pets than we do human beings. I don't want to suffer a prolonged, lingering death. I want to be able to choose when I die – and I'd like to do that in my home, surrounded by my loved ones with dignity – but British law doesn't allow me to do that and that makes me angry."
Meanwhile, Lisa's campaign to raise money for International Animal Rescue has smashed its original target of £10,000 and now stands at £24,096.83, with a new target of £50,000.
Improve International has announced that it is to hold the first conference aimed specifically at Official Veterinarians.
Taking place from 22-23 October 2015, Improve says the conference aims to provide a forum to update OVs on the latest developments and thinking on all aspects of OV work and to provide an opportunity to network and share experiences and ideas.
Organised in association with the Animal & Plant Health Agency (APHA), the Official Veterinarian Conference programme includes a two-day stream of large animal lectures and round-table discussions on topics including Bovine TB, Brucellosis, Anthrax, Sheep Scab and other important diseases.
A lecture stream for small animal practitioners will provide updates on export regulations and small animal exotic diseases, with dedicated lectures for equine practitioners also running on Friday 23 October.
Speakers at the event include Peter Jinman, Chair of the RCVS Certification Sub-Committee (pictured right); Dr Tim Brazil, Directorate of Equine Medicine on the Move and Andy Paterson, Veterinary Head of Intervention Epidemiology. An exhibition of the latest products and services for OVs will run alongside the conference which takes place at the Alexandra House Hotel and Conference Centre, near Swindon, where Improve International is based.
David Babington MRCVS, Managing Director of Improve, said: "The world of the OV is a fast-changing one so this unique event provides an opportunity for OVs to come together in a relaxed atmosphere to hear industry experts deliver up-to-date and practical lectures which will have a positive impact on their work as an OV.
"The programme and content has been developed by our Scientific Committee in collaboration with APHA which is supporting us and we believe it will offer highly relevant content for all OVs."
Are you planning to come to this event? If so, indicate it here, so other VetSurgeon members can see you'll be there!
To book, visit www.officialvet.com
Vet Futures, the joint initiative by the RCVS and the BVA to help the profession prepare for and shape its own future, has published a guest blog in which an academic argues that the profession needs to introduce safeguards to prevent inappropriate profit-seeking behaviour.
David Main is Professor of Animal Welfare at the School of Veterinary Sciences at the University of Bristol, with research interests in welfare assessment, animal welfare education and intervention strategies to improve welfare.
In his blog (www.vetfutures.org.uk/discuss), Professor Main says he believes the vast majority of individual veterinary surgeons and practices are not motivated by money and do have animals’ best interests at heart, but that the differences between the business structure of veterinary and medical practitioners in the UK means the profession is always at risk of standing accused of excessive profiteering.
He said: “Since we still live in the age of the media scare story, it would seem prudent for the profession to embed some anti-profit seeking safeguards in our regulatory controls before, rather than after, a problem is highlighted.” One suggestion he makes is for the prohibition of turnover-based incentive schemes in favour of incentives based on health outcomes.
He believes that such safeguards, which he says could be incorporated into the RCVS Practice Standards Scheme, would be a “healthy demonstration” that the profession has animal welfare rather than profit as its main priority.
Professor Main also argues that the profession urgently needs to deliver on society’s expectation of vets as animal welfare experts: “Veterinarians could perhaps... do more at an individual level to act as animal welfare advocates. It is easy to inform clients on the technical rationale for a specific husbandry change but then walk away knowing full well the client will not action the advice. In the medical profession, advanced communication techniques are becoming more widely accepted to promote positive change within their patients. Perhaps we should be more explicit in teaching our veterinary students influencing skills.”
In response to David’s blog, this month’s Vet Futures poll asks visitors ‘Do vets always act as animal welfare advocates?’
The previous month’s poll, which was based on an article co-written by Erwin Hohn and Adi Nell from MediVet, asked to what extent vets would be willing to work collaboratively with others if it would benefit all. Of the 50 people who answered the poll, 60% said they would be completely willing to work with others, 32% a lot and 8% to some degree – no one said they would be unwilling to work with others.
CVS has announced its acquisition of the Dovecote Veterinary Hospital, a general and referral practice based in Castle Donington near Derby.
The Dovecote offers a range of referral services including digital X-ray, MRI and CT scanning capability. Its directors, Andrew Robinson, a European RCVS Recognised Specialist in Small Animal Surgery, and Alison Robinson have been appointed joint Clinical Directors.
Dovecote joins ChesterGates Veterinary Specialists in Chester, Norfolk-based Grove Referrals and St David's Veterinary Group in Devon in CVS' referral practice portfolio. The Group also has a new veterinary hospital - Lumbry Park Veterinary Specialists - under construction at Alton, Hampshire; opening in October 2015.
In addition to the Dovecote, CVS has announced the acquisition of further first opinion practices based in Yorkshire and Wales. They are:
Simon Innes, Chief Executive of CVS, said: "These latest acquisitions show continued progress towards our goal of building a strong presence throughout all sectors of veterinary practice. It is a particularly exciting time for our referral team and we are delighted to welcome the team from Dovecote, as well as the other new practices which have joined us recently."
Elanco Animal Health has launched an updated Atopica Comfort Club, a support initiative for veterinary professionals treating either canine atopic dermatitis or feline allergic dermatitis cases with Atopica.
The Atopica Comfort Club loyalty scheme now has a new website which enables all members of the practice team to see the cases being managed and the offers available for new and existing users post diagnosis. The initiative provides veterinary practices with a free of charge Atopica redemption scheme through both induction and maintenance periods.
Elanco says the new website will also enable veterinary practices to view and redeem offers instantly, receive reminders about offers and updates together with emails to confirm offers have been redeemed and the products despatched.
Alice Laurens, DVM MRCVS, Dermatology Marketing Manager at Elanco Animal Health, said: “The Comfort Club loyalty scheme embraces a multi-modal approach and ensures better comfort is provided to Atopica patients with options to offer a flea product, shampoo, essential fatty acids and an adapted diet.”
To support the new Atopica Comfort Club loyalty program, Elanco has also produced a ‘practice log book’ to enable vets to record details on each case which can then be entered onto the Comfort Club website.
For further information, or to book a lunch and learn meeting, please contact your local Elanco Animal Health key account manager or email elancoCAH.uk@elanco.com.
The RCVS reports that its alternative dispute resolution (ADR) trial is now nearing completion with over two-thirds of its target number of cases either resolved or in process.
The year-long trial, which began in November 2014, aims to gather the evidence needed to develop a permanent scheme which would provide a way of adjudicating on concerns raised about a veterinary surgeon that do not meet the RCVS threshold of serious professional misconduct.
The aim of the trial, which is administered by the independent, not-for-profit Ombudsman Services, is to make determinations on around 100 cases in order to gather information about types of concern, time taken to resolve disputes, recommendations and how likely each party is to accept recommendations. As of this week some 72 cases have been referred to the trial scheme, with final decisions made in relation to 54 of these cases.
RCVS CEO Nick Stace was responsible for pushing forward the trial believing that “what is good for the consumer is good for the profession”. The College also says it brings it into line with a European Union Directive on alternative dispute resolution which, while not legally binding, specifies that regulators and other ‘competent authorities’ should have consumer redress systems in place.
Nick said: “The majority of cases are either being determined in the veterinary surgeon’s favour or finding that they need take no further action in order to resolve the dispute. Where recommendations have been made in favour of the client, the suggested remedies have generally been for a small goodwill payment to be made.
“However, the trial has not been without some frustrations so far. The fact that participation in the trial is entirely voluntary has meant that, in many cases, members of the profession have chosen not to take part.
“With this in mind, it is very important to stress the benefits of the trial to the profession – chiefly that many of the vets who chose to take part have had their actions exonerated by Ombudsman Services in a way that a concern being closed by our Professional Conduct Department does not. For clients, where a vet does have a case to answer, it gives them the chance to seek recompense without having to resort to legal action.
“Regardless of which way the decision goes in any of these cases, participating in the trial can bring these often long-standing and burdensome disputes to a close.”
The trial will continue to run until the end of October and a full report and recommendations will be presented to RCVS Council at its meeting on Thursday 5 November 2015. Full details of the trial and its parameters can be found at www.rcvs.org.uk/adr
Bayer Animal Health has announced changes to the product indications for Baytril 50mg/ml and 100mg/ml Solutions for Injection, which both contain enrofloxacin.
Baytril 50mg/ml and 100mg/ml Solutions for Injection, now have licensed indications for the treatment of sheep and goats.
Baytril 50mg/ml and 100mg/ml* Solutions for Injection are now licensed for the treatment of acute mycoplasma-associated arthritis due to enrofloxacin- susceptible strains of Mycoplasma bovis in cattle (*in cattle less than 2 years old.)
For the treatment of acute severe mastitis caused by enrofloxacin - susceptible strains ofEscherichia coli in cattle, the second injection of Baytril 100 mg/ml Solution for Injection may now be given subcutaneously, 24 hours after the first dose administered by intravenous injection. In this case, the withdrawal period following subcutaneous injection should be applied.
For more information, refer to the product data sheets at www.noahcompendium.co.uk and SPCs or speak to your local Bayer Animal Health representative.
Scientists from the Animal Health Trust, the Wellcome Trust Sanger Institute and the University of St. Andrews have pinpointed the genes which allow the bacteria responsible for strangles to thrive, thereby paving the way for the development of a vaccine.
In the study, which the researchers say was the largest of its kind, 224 samples of Streptococcus equi (S. equi) were procured from horses around the globe to try and find a common bacterial ancestor from which modern strains would have developed. Despite the disease first being described in 1251, the researchers were surprised at the genetic similarity of the samples and identified a total population replacement at the 19th or early 20th century. This corresponds to a period when horses from around the world were brought together in global conflicts including World War I, where an estimated eight million horses died on the battlefield.
Dr Simon Harris from the Wellcome Trust Sanger Institute said: “The mobilisation and mixing of horses in conflicts such as WWI provided perfect conditions for S. equi to thrive. This combined with high mortality rates among the horses and their replacement with young susceptible horses could explain what we see around the world today".
While loss of diversity could be considered detrimental to bacterial populations, S. equi still infects more than 20,000 horses in the UK alone each year. Its success, researchers believe, is due to its ability to persist in some horses for years after they have recovered from strangles, where the bug can evolve to evade the horse’s immune system.
Dr Andrew Waller, Head of Bacteriology at the Animal Health Trust said: “The data we have gathered in this study has enabled us to pinpoint the genes that help the bacteria to persist, spread and thrive in the horse population. This research provides an unprecedented opportunity to reduce the impact of and prevent strangles in future generations of horses.”
The AHT says that the ability of S. equi to adapt to living in a persistent state within its host and still infect new horses mirrors the situation with HIV and the bacteria that causes tuberculosis in humans. Dr Matthew Holden from the Wellcome Trust Sanger Institute and the University of St Andrews said: “Unravelling the complex population dynamics of S. equi sheds new light on the balancing act between acute and persistent infection that is going on in many pathogens. Not only does this collection of whole-genome sequences for S. equi offer hope for an effective strangles vaccine, it also provides us with a useful model for understanding persistent infection in humans.”
Lincolnshire veterinary surgeon David Bull MRCVS has won a Vet Futures ‘Headlines of tomorrow’ competition with his entry: ‘Vets and medics collaborate to prevent human and animal obesity’.
The competition was held at BSAVA Congress in April where Vet Futures-themed fortune cookies contained a message asking those attending ‘What future headline do you want to see?’ and providing a weblink to enter the competition.
David, a joint partner at Vets4Pets in Lincoln South and an Advanced Practitioner in General Small Animal Surgery, said: "The headline was inspired by topical issues, having ‘One Health’ in mind and the issue of obesity in our patients, as well as the general human population. I feel that these are some of the big issues of our time, especially that of obesity which has been linked to so many other diseases and is essentially a self-induced problem.
“We see so many overweight cats, dogs and rabbits on a daily basis. It seems to be becoming a more common problem, as well as seemingly more accepted in society. This is to the extent that we have some clients that come in worried because they have been told that their dog is too thin, when in actual fact they are in an ideal body condition and are being compared to overweight pets which have become perceived as normal.”
Some of the other topics raised in the competition include the veterinary profession taking the lead in tackling ‘superbugs’, veterinary surgeons topping job satisfaction and wellbeing polls and the profession taking a leading role in One Health and medical advancements.
Ceva Animal Health has launched Libeo, a new four-way break, palatable furosemide for the management of heart failure in dogs.
According to the company, furosemide - a diuretic - is the most frequently used treatment for the management of heart failure because it helps reduce pulmonary oedema and its quick onset of action is associated with a noticeable reduction in clinical signs.
However, Ceva highlights the fact that long-term under or over-dosing can have profound health implications for the patient, and says that current recommendations are to reduce the dose to the minimum effective dose as soon as the animal is stable and only increase it if required due to deterioration in heart function.
Ceva says that unlike other furosemides, Libeo has been designed solely for the veterinary market - specifically to facilitate easy and accurate dosing.
The four-way break tablet is available in a traditional 40mg tablet size as well as a unique 10mg size for small patients. The clover-shaped tablet is chicken-flavoured, designed to make it easier for owners to dose their pets and help improve long-term owner compliance. Each box of Libeo contains 120 blister-packed tablets, removing the need for someone to have to count out tablets.
Rob McLintock MRCVS, Companion Animal Business Unit Manager at Ceva Animal Health said: “87% of vets in the UK believe that the dose of furosemide given to pets by their owners is adversely affected by how difficult it is to split the tablets1. This is especially likely to affect pets whose owners are less dextrous or have difficulties using their hands. Libeo is both easy to administer and effective, thereby improving owner compliance and the long term health and welfare of their pets.”
Reference
Virbac has launched Neoprinil, an eprinomectin pour-on solution indicated for use against internal and external parasites in cattle, including gut and lungworms, mange mites, sucking and chewing lice, horn flies and warbles.
Neoprinil has a zero-day withdrawal period in milk and can be administered using the company's Farmpack and Flexibag.
The Farmpack is a backpack which holds a Flexibag of Neoprinil solution. The Flexibag is a bag designed to protect medication and preserve it once it has been opened. The two together were awarded the 2014 PharmaPack Award for Innovative Packaging.
Neoprinil offers a one year stability period once it has first been opened and requires no special conditions for storage. It is presented in 2.5L, 4.5l and 8l pack sizes.
Product Manager for Large Animals Brigitte Goasduf MRCVS said: "A high worm burden can have adverse effects on the herd's productivity and performance and so it is advisable to ensure infected animals are treated as part of a Herd Health Plan. Eprinomectin is a tried and trusted parasiticide and studies confirm that it can have a positive impact on both milk production and on weight gain. Its zero day withdrawal period is a major benefit for dairy farmers.
"With the launch first of Deltanil and, now, Neoprinil, we are reinforcing our commitment to work with veterinary surgeons and farmers to understand the everyday challenges they face and to provide practical, effective solutions. We offer a comprehensive parasiticide range with a dispensing system that sets a new standard for convenience and ease of use."
The RCVS has published a new video which explains the Professional Development Phase (PDP) and highlights the support it provides for new veterinary graduates as they develop their Year One Competences.
In the video, Victoria Henry MRCVS - who works at Mandeville Veterinary Hospital in Northolt - speaks about how the PDP has helped her move from being a newly-qualified graduate to becoming a confident practitioner. She said: “It’s a massive transition coming out of vet school and going into practice – you suddenly have all the responsibility and it’s all on you. The PDP gives you goalposts to work towards and flags up the areas you don’t have much practice in; it helps you to reflect on what you’ve been doing and assess yourself.”
Jeremy Stewart, the Head Veterinary Surgeon at Mandeville Veterinary Hospital, talks about how the PDP helps employers to support and develop graduates like Victoria by building their confidence and helping them gain the experience they need for practice life.
The video also highlights the support available for graduates undertaking the PDP and features Julian Wells, one of the five Postgraduate Deans who help graduates undertaking the PDP by providing advice on any issues they may encounter, checking their progress and confirming when they have completed it. He also describes how the PDP helps graduates to understand the mentoring role in practice, which they can then provide to new graduates as they progress through their own careers.
Christine Warman, Head of Education at the RCVS, said: “With 859 new UK graduates having just joined the Register, we thought this video would be helpful in setting out why the PDP can be so crucial in helping to build the confidence and experience of new graduates, as well as the fact that it can easily be incorporated into day-to-day work.”
More information about the PDP is available by visiting www.rcvs.org.uk/pdp or by emailing pdp@rcvs.org.uk.
Veterinary surgeons who wish to sign up to the Professional Development Record can do so by visiting www.rcvs-pdr.org.uk
Researchers at the Animal Health Trust are appealing for information from veterinary surgeons who have seen recent Eosinophilic Keratitis (EK) conditions, an emerging issue in UK equine ophthalmology.
The AHT says that despite the increased awareness of EK worldwide, the aetiopathogenesis of the disease remains poorly understood and probably underdiagnosed. The charity is looking to define the pathogenesis and determine why some horses are particularly susceptible to this condition, in particular looking for epidemiological links, environmental factors and parasitic infestation.
Many of the clinical signs of EK are non-specific and similar to other corneal conditions such as blepharospasm, chemosis, conjunctival hyperaemia, epiphora or perilesional oedema. More specific signs include caseous mucoid discharge and white/yellow plaques often localised in the peripheral cornea. The degree of pain varies and concurrent ulceration is almost always present. Conjunctivitis may also occur in association with the keratitis or as a unique disease entity.
EK can have variable clinical presentations, from a thick caseous accumulation to a more superficial plaque of “ground-glass” appearance. They may present as chronic non-healing ulcers that respond quickly to the use of topical steroids and/or ciclosporin, or present with marked ocular discomfort and require superficial keratectomy to resolve the condition.
Two different corneal locations are classically (though not exclusively) involved in EK, the medial perilimbal cornea, often under the third eyelid, or the lateral perilimbal cornea, which may progress axially towards the central cornea.
The charity is also providing free cytology tests for corneal scrapes to help vets diagnose EK earlier, thereby avoiding secondary complications that can lead to permanent visionary impairment.
If you have seen cases that have either been diagnosed as or that you suspect to be Eosinophilic Keratitis this year, contact Sonia Gonzalez-Medina on 01638 751000 Ext: 1203 or sonia.gonzalez-medina@aht.org.uk.
For more information and to download a copy of the submission form to accompany samples, visit www.aht.org.uk/EKstudy.
The RCVS is encouraging veterinary surgeons, veterinary nurses and other members of the practice team to respond to a government consultation on changing the law to introduce English language testing for veterinary surgeons who have qualified from elsewhere in the European Union.
Under the proposals outlined in the consultation by the Department for Environment, Food and Rural Affairs (Defra), the test would apply before an individual joined the Register and only where the RCVS had ‘serious and concrete doubts’ about their English language abilities. The plan to consult on this issue had been welcomed by RCVS Council at its June 2015 meeting.
Every year, around half of all new veterinary surgeon registrants are from outside the UK, the majority from other EU or European Economic Area (EEA) countries. These individuals fall within the scope of the Mutual Recognition of Professional Qualifications (MRPQ) Directive, which applies to all EU nationals wishing to practise in a regulated profession in another member state.
Last year, a revised version of the MRPQ Directive came into force, which made a number of changes, including clarifying and reinforcing the role of competent authorities such as the RCVS. One of these changes is that language testing is expressly permitted, but only where serious concerns have been identified.
Gordon Hockey, RCVS Registrar, said: “Under the current legislation the College is not able to bar someone from joining the Register, and therefore practising, on the basis of language ability, even where we may have serious concerns.
“I would encourage all veterinary surgeons, veterinary nurses and other members of the practice team to engage with this consultation and consider whether the College should have the right to impose a language test where it has serious doubts, more in line with medical doctors, and the form such testing would take.”
Under the proposals, applicants would be asked a series of questions concerning their language qualifications, experience and general ability to use the English language before registering. Depending on how they answer the questions they may then have to pass a language test before registering, or delay their application while they improve their language skills.
The consultation results will inform the College’s work with Defra to determine whether to proceed with implementation and, if so, to develop the most appropriate system of language testing. The College would implement language testing for veterinary nurses in parallel with any changes for veterinary surgeons.
Those who wish to take part in the consultation can do so at https://consult.defra.gov.uk/animal-health-and-welfare/vet_language_controls. The deadline for responses is Wednesday 30 September 2015.
CVS has announced that it is to support the Small Animal Veterinary Surveillance Network (SAVSNET), a charity initiative run jointly by the BSAVA and the University of Liverpool to monitor health and illness in companion animals using anonymised data from veterinary practices and laboratories.
The group will be linking its practices, of which there are now more than 290, to SAVSNET through their practice management systems in a rollout that will continue until the end of the year.
Through its research and analysis, SAVSNET aims to monitor disease trends over time; identify populations at risk and monitor treatments and outcomes. It also aims to provide data and improve public awareness of small animal diseases and prevention. One of its projects delivers near-real-time (within 24 hours) practice-based syndromic surveillance based on data received from participating veterinary surgeons, who through a single mouse click, record information at the end of each consultation through their practice management system. The data is automatically sent to SAVSNET for secure storage and analysis. The whole process is designed to avoid any impact on a practices already busy work flow.
Dr Alan Radford, one of SAVSNET’s principal investigators, said: "Reusing electronic health data has a massive potential to improve animal and human health. SAVSNET is one project leading the way in this research and it is great to be working with CVS, with its scale and also its focus on high quality veterinary care.
"Working together, SAVSNET and members of the CVS team can really help understand in a new way the diseases seen by the populations under our care. As a small thank you for participation, practices that take part are provided with a secure on-line portal where they can see free anonymised benchmarking statistics including disease data and antibacterial use. Greater knowledge will enable us to target interventions to those animals most at risk, to identify risk factors for disease and to focus veterinary research efforts."
Marcus Evans, Head of Practice Management Systems at CVS said: "We are very impressed at the projects being carried out by the SAVSNET team and are keen to support its work, particularly as our veterinary teams can do it so quickly and easily through RoboVet, our practice management system. As a large veterinary group, and one that is continuing to grow rapidly, our support will add significant weight to SAVNET's efforts and we are delighted to be contributing to such valuable research."